1. Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation
- Author
-
Nurilign Bulcha, Omar Saeed, Ying Xian, Mario J. Garcia, Tanush Gupta, Lee H. Schwamm, Ulrich P. Jorde, Shreyansh Shah, Eric E. Smith, Gregg C. Fonarow, Roland A. Matsouaka, Shuaiqi Zhang, and Snehal R. Patel
- Subjects
Aging ,medicine.medical_specialty ,Adverse outcomes ,Clinical Sciences ,Hemorrhage ,Nursing ,Cardiorespiratory Medicine and Haematology ,030204 cardiovascular system & hematology ,Cardiovascular ,Medicare ,Brain Ischemia ,03 medical and health sciences ,0302 clinical medicine ,Clinical Research ,Internal medicine ,Atrial Fibrillation ,medicine ,Humans ,030212 general & internal medicine ,Mortality ,Adverse effect ,Stroke ,Oral anticoagulation ,Aged ,Ischemic Stroke ,Heart Failure ,business.industry ,Hazard ratio ,Anticoagulants ,Atrial fibrillation ,medicine.disease ,United States ,Brain Disorders ,Heart Disease ,Cardiovascular System & Hematology ,Heart failure ,Ischemic stroke ,Cardiology ,Oral Anticoagulation ,Cardiology and Cardiovascular Medicine ,business - Abstract
BackgroundThe safety and effectiveness of oral anticoagulation (OAC) after an ischemic stroke in older patients with heart failure (HF) without atrial fibrillation remains uncertain.MethodsUtilizing Get With The Guidelines Stroke national clinical registry data linked to Medicare claims from 2009-2014, we assessed the outcomes of eligible patients with a history of HF who were initiated on OAC during a hospitalization for an acute ischemic stroke. The cumulative incidences of adverse events were calculated using Kaplan-Meier curves and adjusted Cox proportional hazard ratios were compared between patients discharged on or off OAC.ResultsA total of 8,261 patients from 1,370 sites were discharged alive after an acute ischemic stroke and met eligibility criteria. Of those, 747 (9.0%) were initiated on OAC. Patients on OAC were younger (77.2±8.0 vs. 80.5±8.9 years, p
- Published
- 2021